Clik here to view.
ABEC Advances Single-Use Bioreactor Volumes to 6,000 Liters
BETHLEHEM, Pa. ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today announced the availability of Custom Single Run (CSR®) Bioreactors with working...
View ArticleClik here to view.
ABEC Sets Benchmark in Productivity for Flexible Biopharmaceutical Manufacturing
BETHLEHEM, Pa. ABEC, a global provider of integrated solutions and services for biopharmaceutical manufacturing, today introduced the Flexible Manufacturing Platform, a fully-customizable cell...
View ArticleClik here to view.
New Cook Medical Paclitaxel Data Presented at CIRSE Confirms Safety of...
BARCELONA, Spain Michael D. Dake, MD, presented at the Cardiovascular and Interventional Radiological Society of Europe (CIRSE) conference regarding new data on the use of Zilver® PTX®, Cook...
View ArticleClik here to view.
NanoView Biosciences and Quantum Design Korea Enter Into Distribution Agreement
BOSTON NanoView Biosciences, Inc., and Quantum Design Korea, a subsidiary of Quantum Design International, today announced an exclusive distribution agreement for NanoView’s ExoView™ platform in...
View ArticleClik here to view.
Specsavers Installs the 350th Topcon Maestro Fully Automated OCT
OAKLAND, N.J. & PORT MELBOURNE, Australia Topcon Medical Systems (TMS), of Oakland, NJ, USA, a leading provider of diagnostic equipment and software solutions for the eye care industry, and...
View ArticleClik here to view.
Atomwise Announces Largest China-US Collaboration for AI Drug Discovery
SAN FRANCISCO Atomwise Inc. (“Atomwise”), the leader in artificial intelligence (AI) for drug discovery, today announced a collaboration with Hansoh Pharmaceutical Group Company Limited (“Hansoh...
View ArticleClik here to view.
Hansoh Pharma and Atomwise Launch Strategic AI Drug Discovery Collaboration...
SHANGHAI & SAN FRANCISCO Hansoh Pharmaceutical Group Company Limited (“Hansoh Pharma”), a leading biopharmaceutical company in China, and Atomwise, Inc. (“Atomwise”), the leader in artificial...
View ArticleClik here to view.
ABEC树立灵活生物制药生产的生产力基准
宾夕法尼亚州伯利恒 (美国商业资讯)–生物制药生产集成解决方案和服务的全球提供商ABEC今天推出了可完全定制的细胞培养平台Flexible Manufacturing Platform，以用于灵活、大批量的生物制药生产。Flexible Manufacturing...
View ArticleClik here to view.
ABEC将一次性生物反应器的容量提升至6,000升
宾夕法尼亚州伯利恒 (美国商业资讯)–生物制药生产集成解决方案和服务的全球提供商ABEC今天宣布推出工作容量高达6,000升的Custom Single Run (CSR®)生物反应器。6,000L的容量是对ABEC业界领先的4,000L容量的提升，同时持续提供与不锈钢系统相当的性能。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Chugai Presents Results from Second Positive Global Phase III Clinical Study...
TOKYO Chugai Pharmaceutical Co., Ltd. (TOKYO:4519) announced that the results from SAkuraStar Study were presented at the Congress of European Committee for Treatment and Research in Multiple...
View ArticleClik here to view.
翰森制药和Atomwise启动多项治疗领域的人工智能药物发现战略合作
上海和旧金山 (美国商业资讯)–中国领先的生物制药公司翰森制药集团有限公司（Hansoh Pharmaceutical Group Company Limited，“翰森制药”）和药物发现人工智能(AI)领域的领先者Atomwise, Inc. (“Atomwise”)宣布合作设计和发现潜在的候选药物，涉及多项治疗领域最多11个未披露的靶蛋白。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Gain Therapeuticsがジェフリー・ライリーの取締役就任を発表
スイス・ルガーノ （ビジネスワイヤ） — Gain Therapeutics SA（代謝異常と中枢神経系疾患の先天異常に関与するリソソーム酵素を標的とする新規治療薬の創薬と開発に取り組むバイオテクノロジー企業）は本日、ジェフリー・ライリーがGain Therapeuticsの独立取締役に就任したことを発表しました。...
View ArticleClik here to view.
Dr. Reddy’s Announces the Launch of Over-the-Counter, Store-Brand Equivalent...
HYDERABAD, India & PRINCETON, N.J. Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the...
View ArticleClik here to view.
Lygos Secures Strategic Investment from CJ CheilJedang to Accelerate Growth...
BERKELEY, Calif. Lygos, Inc., a full-stack producer of specialty chemicals that deliver high-value performance without environmental toxicity, today announced that CJ CheilJedang (CJCJ), a global...
View ArticleClik here to view.
Hansoh PharmaとAtomwiseが複数の治療領域を対象としたAI創薬で戦略的協業を開始
上海 & サンフランシスコ （ビジネスワイヤ） — 中国の大手バイオ医薬品企業Hansoh Pharmaceutical Group Company Limited（翰森製薬集団有限公司、ハンソー・ファーマシューティカル）と創薬向け人工知能（AI）分野のリーダー企業Atomwise,...
View ArticleClik here to view.
AVITA Medical Receives U.S. FDA Investigational Device Exemption Approval of...
VALENCIA, Calif. & MELBOURNE, Australia AVITA Medical (ASX: AVH, OTCQX: AVMXY), a regenerative medicine company focused on the development and commercialization of innovative therapies...
View ArticleClik here to view.
Solasia Announces Patient Registration Reached Target Number of Cases for...
TOKYO Solasia Pharma K.K. (TSE:4597, Headquarters: Tokyo, President & CEO: Yoshihiro Arai, hereinafter “Solasia”), a specialty pharmaceutical company based in Asia, today announced that patient...
View ArticleClik here to view.
ソレイジア・ファーマ：開発品SP-02 第Ⅱ相臨床試験（最終試験）被験者の目標症例数到達のお知らせ
東京 （ビジネスワイヤ） – 当社は、現在実施中の開発品SP-02（新規抗がん剤、国際一般名：darinaparsin、一般名：ダリナパルシン）の第Ⅱ相臨床試験（以下、「本試験」）について、このたび被験者の登録が目標症例数に到達いたしましたのでお知らせいたします。...
View ArticleClik here to view.
PSE計畫加入西門子
倫敦 (美國商業資訊)–先進製程建模(APM)軟體和服務的一流供應商Process Systems Enterprise (PSE)今天宣佈，它計畫在訂於2019年第四季完成的交易中被西門子公司收購。PSE的160多項作業將整合到西門子數位工業的製程自動化業務部門。目前的PSE管理團隊將保持不變。...
View ArticleClik here to view.
PSE计划加入西门子
伦敦 (美国商业资讯)–高级过程建模(APM)软件和服务的领先供应商Process Systems Enterprise (PSE)今天宣布，它计划在定于2019年第四季度的交易中被西门子公司收购。PSE的160多项运营将纳入到西门子数字工业的过程自动化业务部门。目前的PSE管理团队将保持不变。...
View Article